Press release
Microsatellite Stable Colorectal Cancer Market Report 2032: Epidemiology Data, Pipeline Therapies, Treatment, and Key Companies by DelveInsight
Microsatellite Stable Colorectal Cancer Market
To know more about Microsatellite Stable Colorectal Cancer Market, click here: https://www.delveinsight.com/report-store/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some facts of Microsatellite Stable Colorectal Cancer Market Report are:
• According to DelveInsight, Microsatellite Stable Colorectal Cancer Market is expected to grow at DECENT CAGR during the forecast period.
• Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2.
• Keytruda, Opdivo with or without Yervoy, and Braftovi in combination with Erbitux are recent additions to the Metastatic Colorectal Cancer treatment market.
• Talking about gender-predisposition, CRC is the third most commonly diagnosed cancer in males and the second in females. It is most frequently diagnosed in people of age group 65-74.
• Targeting CTLA-4: A Possible Solution for Microsatellite-Stable Colorectal Cancer: In this study, researchers explored a combination of chemotherapies and immunotherapies for MSS RAS mutant metastatic colorectal cancer. The trial involved using a combination of FOLFOX (a chemotherapy regimen), durvalumab (an anti-PD-L1 drug), and tremelimumab (an anti-CTLA-4 drug) as first-line treatment. The goal was to promote the recruitment and activation of the adaptive immune system at the tumor level, resulting in clinical benefit for a significant number of patients.
• Global Randomized Phase II Trial: A global randomized phase II trial for microsatellite-stable metastatic colorectal cancer is currently enrolling patients (ClinicalTrials.gov identifier NCT05608044). This trial aims to evaluate novel treatment approaches for MSS colorectal cancer.
To know more about Microsatellite Stable Colorectal Cancer Market, click here: https://www.delveinsight.com/sample-request/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of Microsatellite Stable Colorectal Cancer Market Report:
• The report covers the descriptive overview of Microsatellite Stable Colorectal Cancer, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
• Comprehensive insight has been provided into the Microsatellite Stable Colorectal Cancer epidemiology and treatment in the 7MM
• Additionally, an all-inclusive account of both the current and emerging therapies for Microsatellite Stable Colorectal Cancer is provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
• A detailed review of the Microsatellite Stable Colorectal Cancer market; historical and forecasted is included in the report, covering drug outreach in the 7MM
• The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Microsatellite Stable Colorectal Cancer market
Some of Microsatellite Stable Colorectal Cancer Companies in the market:
• Gritstone Oncology
• Merck Sharp & Dohme Corp.
• Arrys Therapeutics
• NeoImmuneTech
• And Others
To know more about Microsatellite Stable Colorectal Cancer Market, click here: https://www.delveinsight.com/report-store/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Microsatellite Stable Colorectal Cancer Drugs:
• GRANITE
• MK7123-034
• NT-I7
• TPST-149
• And Many Others
To know more about Microsatellite Stable Colorectal Cancer Market, click here: https://www.delveinsight.com/sample-request/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents:
1. Key Insights
2. Executive Summary of Microsatellite Stable Colorectal Cancer
3. Competitive Intelligence Analysis for Microsatellite Stable Colorectal Cancer
4. Microsatellite Stable Colorectal Cancer: Market Overview at a Glance
5. Microsatellite Stable Colorectal Cancer: Disease Background and Overview
6. Microsatellite Stable Colorectal Cancer Patient Journey
7. Microsatellite Stable Colorectal Cancer Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Microsatellite Stable Colorectal Cancer Unmet Needs
10. Key Endpoints of Microsatellite Stable Colorectal Cancer Treatment
11. Microsatellite Stable Colorectal Cancer Marketed Products
List to be continued in report
12. Microsatellite Stable Colorectal Cancer Emerging Therapies
List to be continued in report
13. Microsatellite Stable Colorectal Cancer: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Microsatellite Stable Colorectal Cancer Market Outlook
16. Access and Reimbursement Overview of Microsatellite Stable Colorectal Cancer
17. KOL Views
18. Microsatellite Stable Colorectal Cancer Market Drivers
19. Microsatellite Stable Colorectal Cancer Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
To know more about Microsatellite Stable Colorectal Cancer Market, click here: https://www.delveinsight.com/sample-request/microsatellite-stable-colorectal-cancer-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Trending Reports:
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Hemodynamic Monitoring Systems Market: https://www.delveinsight.com/report-store/hemodynamic-monitoring-system-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Brain/cranial Implants Market: https://www.delveinsight.com/report-store/brain-implants-market-market
• Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/automated-external-defibrillator-aed-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Alopecia Aerata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Alopecia Areata Market: https://www.delveinsight.com/report-store/alopecia-areata-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myeloid-leukemia-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market
• Allergic Rhinitis Market: https://www.delveinsight.com/report-store/allergic-rhinitis-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/hearing-aid-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Adult Growth Hormone Deficiency Market: https://www.delveinsight.com/report-store/growth-hormone-deficiency-ghd-market
• Dysthymia Market: https://www.delveinsight.com/report-store/major-depressive-disorder-market
• Hyperuricemia Market: https://www.delveinsight.com/report-store/hyperuricemia-pipeline-insight
• Defibrillators Market: https://www.delveinsight.com/report-store/defibrillator-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Bronchial Spasm Market: https://www.delveinsight.com/report-store/bronchial-spasm-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +14699457679
Website: https://www.delveinsight.com
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Microsatellite Stable Colorectal Cancer Market Report 2032: Epidemiology Data, Pipeline Therapies, Treatment, and Key Companies by DelveInsight here
News-ID: 3423606 • Views: …
More Releases from DelveInsight Business Research
Vitiligo Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA App …
The "Vitiligo Pipeline Insight, 2025" report by DelveInsight delivers an in-depth view of the current clinical development scenario along with the future growth trajectory of the Vitiligo Market.
As per DelveInsight's evaluation, the global Vitiligo treatment pipeline features 20+ leading companies actively engaged in developing 20+ therapeutic candidates. The analysis covers Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and developmental updates.
The Vitiligo Pipeline report offers extensive commercial and clinical…
Myelodysplastic Syndrome Competitive Landscape 2025: Clinical Trial Analysis, Th …
DelveInsight's, "Myelodysplastic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 120+ companies and 150+ pipeline drugs in Myelodysplastic Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Myelodysplastic Syndrome Pipeline Report
• DelveInsight's Myelodysplastic Syndrome…
Fibromyalgia Competitive Landscape 2025: Clinical Trial Analysis, Therapies, FDA …
According to DelveInsight, the global Fibromyalgia pipeline features more than eight key companies actively developing over ten treatment candidates. The analysis encompasses ongoing clinical trials, therapeutic mechanisms of action, routes of administration, and recent developments within the Fibromyalgia treatment landscape.
The Fibromyalgia Pipeline 2025 report provides an exhaustive evaluation of pipeline products, ranging from preclinical stages to marketed therapies. It includes comprehensive details on each drug's mechanism of action, clinical trial…
Chronic Wounds Competitive Landscape 2025: Clinical Trial Analysis, Therapies, F …
As per DelveInsight's assessment, globally, Chronic Wounds pipeline constitutes 7+ key companies continuously working towards developing 8+ Chronic Wounds treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Chronic Wounds Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Chronic Wounds Market.
The Chronic Wounds Pipeline report embraces in-depth commercial and clinical assessment…
More Releases for Colorectal
Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685
This latest report researches the…
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and…
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.
For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @
https://goo.gl/1HQ4Fn .
Report Description:
Pharmaceutical guide Colorectal Cancer - Pipeline Review H1…
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die…
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in…
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which…
